BioSpace News Archive

Pharm Country

COVAXIN™ (BBV152) Booster Shown to Neutralize Both Omicron and Delta Variants of SARS-CoV-2

Ocugen, Inc. (NASDAQ: OCGN), and its partner, Bharat Biotech, today announced results from a study conducted at Emory University demonstrating that sera from subjects who received a booster dose of candidate vaccine COVAXIN.

January 12, 2022
·
10 min read
Business

QUEST DIAGNOSTICS ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS

Quest Diagnostics Incorporated announced today preliminary financial results for the fourth quarter and full year 2021.

January 12, 2022
·
9 min read
Drug Development

Positive Top-Line Results of Pfizer’s Phase 3 Study Exploring Coadministration of PREVNAR 20™ With Pfizer-BioNTech COVID-19 Vaccine in Older Adults Released

Pfizer Inc. (NYSE:PFE) today announced positive top-line results from a Phase 3 study (B74710126) describing the safety and immunogenicity of PREVNAR 20™ (Pneumococcal 20-valent Conjugate Vaccine) in 570 adults in the United States 65 years of age or older when administered at the same time as the Pfizer-BioNTech COVID-19 Vaccine or when each vaccine was given with placebo.

January 12, 2022
·
20 min read
Deals

Clearlake Capital-Backed TEAM Technologies Acquires iiMED, a Nearshore Specialty Manufacturer of FDA Class I & II Consumable Medical Devices

Strategic Acquisition Strengthens TEAM’s Position as a Partner to Healthcare OEMs and Accelerates Growth in the Healthcare Specialty Manufacturing Market.

January 12, 2022
·
5 min read
DALI Medical’s SAN®Light Passive Safety Needle coupled with a novel Drug Product, Enabling User-friendly Administration

DALI Medical Devices today announced the first commercial implementation of its SAN-Light passive safety needle.

January 12, 2022
·
2 min read
Business

Ginkgo Bioworks Provides Preliminary Unaudited 2021 Revenue Highlights and Business Review

Expects to meet or exceed 2021 performance targets for new cell programs, Foundry revenue, and Biosecurity revenue.

January 12, 2022
·
6 min read
Cipla to Present at the 40th Annual J.P. Morgan Healthcare Conference

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as “Cipla” today announced that it will participate at the 40th Annual J.P. Morgan Healthcare Conference,

January 12, 2022
·
2 min read
Business

Aro Biotherapeutics Expands Leadership Team with Appointment of Sukumar Sakamuri, Ph.D. as Chief Technology Officer

Aro Biotherapeutics today announced the appointment of Sukumar Sakamuri, Ph.D. as Chief Technology Officer and a member of the company’s executive leadership team.

January 12, 2022
·
2 min read
Lone Star Bio

Data Published in Ocular Oncology and Pathology Demonstrates Highly Accurate Performance of DecisionDx®-UMSeq for Patients with Uveal Melanoma

Data Published in Ocular Oncology and Pathology Demonstrates Highly Accurate Performance of DecisionDx®-UM Seq for Patients with Uveal Melanoma.

January 12, 2022
·
8 min read
Business

Hemogenyx Pharmaceuticals and Selexis SA Will Advance Hemogenyx’s Acute Myeloid Leukemia (AML) CDX Bispecific Antibody to Human Trials

Hemogenyx Pharmaceuticals will leverage Selexis’ SUREtechnology Platform™ of protein expression technologies and modular workflows.

January 12, 2022
·
5 min read